Naviter Wealth, LLC Astrazeneca PLC Transaction History

Naviter Wealth, LLC

$809 Million
Q1 2025

A detailed history of Naviter Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Naviter Wealth, LLC holds 66,992 shares of AZN stock, worth $4.62 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

66,992

Previous 68,204 1.78%

Holding current value

$4.62 Million

Previous $4.47 Million 10.18%

% of portfolio

0.61%

Previous 0.55%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	SELL	$65.37 - $77.96 $79,228 - $94,487	-1,212 Reduced 1.78%	66,992 $4.92 Million
Q4 2024 Feb 07, 2025	SELL	$63.2 - $79.58 $86,963 - $109,502	-1,376 Reduced 1.98%	68,204 $4.47 Million
Q3 2024 Oct 16, 2024	SELL	$76.67 - $87.62 $42,168 - $48,191	-550 Reduced 0.78%	69,580 $5.42 Million
Q2 2024 Aug 01, 2024	BUY	$66.81 - $80.83 $465,532 - $563,223	6,968 Added 11.03%	70,130 $5.47 Million
Q1 2024 Apr 18, 2024	BUY	$61.03 - $69.57 $966,349 - $1.1 Million	15,834 Added 33.46%	63,162 $4.28 Million
Q4 2023 Feb 05, 2024	BUY	$61.89 - $69.28 $269,530 - $301,714	4,355 Added 10.13%	47,328 $3.19 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $258,686 - $286,011	3,989 Added 10.23%	42,973 $2.91 Million
Q2 2023 Jul 20, 2023	BUY	$69.91 - $75.81 $346,194 - $375,411	4,952 Added 14.55%	38,984 $2.79 Million
Q1 2023 Apr 12, 2023	SELL	$63.15 - $71.6 $69,022 - $78,258	-1,093 Reduced 3.11%	34,032 $2.36 Million
Q4 2022 Jan 31, 2023	BUY	$54.21 - $70.44 $1.9 Million - $2.47 Million	35,125 New	35,125 $2.38 Million
Q2 2022 Jul 18, 2022	BUY	$59.26 - $71.14 $1.67 Million - $2 Million	28,107 New	28,107 $1.86 Million

Others Institutions Holding AZN

# of Institutions

1,408

Shares Held

512M

Call Options Held

6.95M

Put Options Held

2.95M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $214B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Naviter Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naviter Wealth, LLC with notifications on news.

Account

Naviter Wealth, LLC Astrazeneca PLC Transaction History